Last $2.63 USD
Change Today -0.01 / -0.38%
Volume 664.2K
ATHX On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gil Van Bokkelen Ph.D.

Co-Founder, Chairman and Chief Executive Officer, Athersys, Inc.
AgeTotal Calculated CompensationThis person is connected to 128 board members in 2 different organizations across 1 different industries.

See Board Relationships
52$2,034,488
As of Fiscal Year 2013

Background*

Dr. Gil Van Bokkelen, Ph.D. serves as an Investment Advisor to Early Stage Partners, a venture capital fund based in Ohio. Dr. Van Bokkelen Co-Founded Athersys, Inc. in October 1995 and has been its Chief Executive Officer since 1995. He served as the President of Athersys, Inc. until May 2006. He also played a fundamental role in developing the SMC technology. He has been the Chairman of Athersys, Inc. since August 2000 and has been its Director since 1995. He has been ...

Read Full Background

Corporate Headquarters*

3201 Carnegie Avenue
Cleveland, Ohio 44115

United States

Phone: 216-431-9900
Fax: 216-361-9495

Board Members Memberships*

Director
1995-Present
Co-Founder, Chairman and Chief Executive Officer

Education*

PhD
The Board of Trustees of The Leland Stanford Junior University
BA
University of California Berkeley

Other Affiliations*

Annual Compensation*

Salary$450,000
Bonus$118,800
Total Annual Compensation$568,800

Stock Options*

Restricted Stock Awards$1,188,518
All Other Compensation$12,620

Total Compensation*

Total Annual Cash Compensation$581,420
Total Short Term Compensation$568,800
Other Long Term Compensation$1,201,138
Total Calculated Compensation$2,034,488
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATHX:US $2.63 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$760.5K
John A. Scarlett M.D.Chief Executive Officer, President and Director
Geron Corporation
$569.3K
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
$406.6K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$544.2K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERSYS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.